[HTML][HTML] 18F-labeled, PSMA-targeted radiotracers: leveraging the advantages of radiofluorination for prostate cancer molecular imaging

RA Werner, T Derlin, C Lapa, S Sheikbahaei… - Theranostics, 2020 - ncbi.nlm.nih.gov
Prostate-specific membrane antigen (PSMA)-targeted PET imaging for prostate cancer with
68 Ga-labeled compounds has rapidly become adopted as part of routine clinical care in …

Novel structured reporting systems for theranostic radiotracers

RA Werner, RA Bundschuh, L Bundschuh… - Journal of Nuclear …, 2019 - Soc Nuclear Med
Standardized reporting is more and more routinely implemented in clinical practice, and
such structured reports have a major impact on a large variety of medical fields, such as …

[BOOK][B] Handbook of Nuclear Medicine and Molecular Imaging for Physicists: Radiopharmaceuticals and Clinical Applications, Volume III

M Ljungberg - 2022 - api.taylorfrancis.com
This state-of-the-art handbook, the third and final in a series that provides medical physicists
with a comprehensive overview into the field of nuclear medicine, focuses on highlighting …

Radionuclide-based Diagnosis and Therapy of Prostate Cancer

SE Strand, M Altai, J Strand… - Handbook of Nuclear …, 2022 - taylorfrancis.com
Prostate cancer (PCa) is the most frequent cancer in men in the Western world.
Unfortunately, commonly available imaging modalities have not been shown to significantly …

Introduction of Novel Structured Reporting Systems for PET Radiotracers with Potential Theranostic Applications

RA Werner, R Bundschuh, L Bundschuh… - Journal of Nuclear …, 2019 - Soc Nuclear Med
Standardized reporting is more and more routinely implemented in clinical practice and such
structured reports have a major impact on a large variety of medical fields, eg laboratory …

[PDF][PDF] 18F-fluciclovine 应用于前列腺癌诊断的进展

王恺赟, 苏瑞, 孙晓宇, 蒋军辉, 马琪 - 中南大学学报 (医学版), 2000 - researchgate.net
前列腺癌是发达国家男性发病率最高的恶性肿瘤, 近年来发病率在我国也呈逐年上升趋势.
随着诊疗技术的发展, PET/CT 检查在诊断前列腺癌中的应用日益增加. 为了更加安全 …